Nu-Med Plus (NUMD) EBT Growth (5y) (2017 - 2025)
Nu-Med Plus (NUMD) EBT Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 52.24% |
| Sep 30, 2025 | 51.67% |
| Jun 30, 2025 | 58.15% |
| Mar 31, 2025 | 33.85% |
| Dec 31, 2024 | 45.17% |
| Sep 30, 2024 | 34.13% |
| Jun 30, 2024 | 40.88% |
| Mar 31, 2024 | 44.98% |
| Dec 31, 2023 | 30.68% |
| Sep 30, 2023 | 49.85% |
| Jun 30, 2023 | 31.72% |
| Mar 31, 2023 | 27.16% |
| Dec 31, 2022 | 18.49% |
| Sep 30, 2022 | 15.22% |
| Jun 30, 2022 | 11.43% |
| Mar 31, 2022 | 1.95% |
| Dec 31, 2021 | -48.59% |
| Sep 30, 2021 | 29.72% |
| Jun 30, 2021 | -7.88% |
| Mar 31, 2021 | -42.77% |